Stuart M. Pitson

10.8k total citations
163 papers, 8.2k citations indexed

About

Stuart M. Pitson is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Stuart M. Pitson has authored 163 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Molecular Biology, 66 papers in Cell Biology and 22 papers in Physiology. Recurrent topics in Stuart M. Pitson's work include Sphingolipid Metabolism and Signaling (101 papers), Lipid Membrane Structure and Behavior (36 papers) and Cellular transport and secretion (33 papers). Stuart M. Pitson is often cited by papers focused on Sphingolipid Metabolism and Signaling (101 papers), Lipid Membrane Structure and Behavior (36 papers) and Cellular transport and secretion (33 papers). Stuart M. Pitson collaborates with scholars based in Australia, United States and United Kingdom. Stuart M. Pitson's co-authors include Paul A.B. Moretti, Mathew A. Vadas, Pu Xia, Binks W. Wattenberg, Jennifer R. Gamble, Melissa R. Pitman, Richard J. D’Andrea, Claudine S. Bonder, Julia R. Zebol and Robert J. Seviour and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Stuart M. Pitson

159 papers receiving 8.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart M. Pitson Australia 51 6.4k 2.8k 1.1k 936 673 163 8.2k
Christopher K. Patil United States 11 3.8k 0.6× 1.6k 0.6× 1.4k 1.2× 2.0k 2.1× 693 1.0× 17 6.5k
Besim Öğretmen United States 54 8.3k 1.3× 2.3k 0.8× 1.0k 0.9× 1.2k 1.3× 1.1k 1.7× 148 10.0k
Neil J. Bulleid United Kingdom 50 4.6k 0.7× 4.1k 1.5× 935 0.8× 388 0.4× 203 0.3× 112 7.5k
Gordon C. Shore Canada 49 6.3k 1.0× 1.8k 0.6× 964 0.9× 397 0.4× 931 1.4× 95 8.3k
Robert Ballotti France 58 5.3k 0.8× 4.8k 1.7× 1.5k 1.3× 544 0.6× 1.8k 2.7× 143 9.9k
Hideki Nishitoh Japan 37 5.3k 0.8× 2.1k 0.8× 1.3k 1.1× 767 0.8× 531 0.8× 64 8.2k
Marı́a S. Soengas Spain 32 6.6k 1.0× 1.0k 0.4× 1.4k 1.3× 970 1.0× 2.6k 3.9× 63 8.7k
Estela E. Medrano United States 38 5.9k 0.9× 1.8k 0.7× 1.3k 1.2× 3.8k 4.1× 1.8k 2.6× 81 10.3k
Nicholas Joza France 24 3.7k 0.6× 847 0.3× 1.6k 1.4× 624 0.7× 1.0k 1.5× 25 6.0k
Éva Szegezdi Ireland 31 3.1k 0.5× 2.0k 0.7× 986 0.9× 355 0.4× 600 0.9× 80 5.7k

Countries citing papers authored by Stuart M. Pitson

Since Specialization
Citations

This map shows the geographic impact of Stuart M. Pitson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart M. Pitson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart M. Pitson more than expected).

Fields of papers citing papers by Stuart M. Pitson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart M. Pitson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart M. Pitson. The network helps show where Stuart M. Pitson may publish in the future.

Co-authorship network of co-authors of Stuart M. Pitson

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart M. Pitson. A scholar is included among the top collaborators of Stuart M. Pitson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart M. Pitson. Stuart M. Pitson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mekonnen, Laychiluh, Theodosia Teo, Benjamin Noll, et al.. (2025). A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma. Biomedicine & Pharmacotherapy. 189. 118340–118340.
2.
Ross, David M., et al.. (2024). Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death and Disease. 15(6). 413–413. 23 indexed citations
3.
Li, Manjun, John Toubia, Melinda N. Tea, et al.. (2023). An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma. British Journal of Haematology. 204(2). 566–570. 1 indexed citations
4.
Gargett, Tessa, Lisa M. Ebert, Nga Truong, et al.. (2022). GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer. 10(9). e005187–e005187. 72 indexed citations
5.
Gomez‐Brouchet, Anne, Adeline Ledoux, Sandra De Barros, et al.. (2022). Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters. Cancers. 14(3). 499–499. 1 indexed citations
6.
Ebert, Lisa M., John Toubia, Cameron R. Bastow, et al.. (2022). Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma. Frontiers in Immunology. 13. 850226–850226. 18 indexed citations
7.
Ebert, Lisa M., Kate Vandyke, M. Zahied Johan, et al.. (2021). Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma. Molecular Oncology. 16(6). 1221–1240. 11 indexed citations
8.
Savira, Feby, Ruth Magaye, Bernard L. Flynn, et al.. (2021). Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. Toxicology Letters. 350. 133–142. 9 indexed citations
9.
Li, Manjun, Melinda N. Tea, Melissa R. Pitman, et al.. (2021). Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition. Neoplasia. 24(1). 1–11. 13 indexed citations
10.
Lidgerwood, Grace E., Stuart M. Pitson, Claudine S. Bonder, & Alice Pébay. (2018). Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology. Progress in Lipid Research. 72. 42–54. 31 indexed citations
11.
Zhu, Wenying, Kate E. Jarman, Noor A. Lokman, et al.. (2017). CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1. Cancer Research. 77(18). 4823–4834. 24 indexed citations
12.
Pitman, Melissa R., Maurizio Costabile, & Stuart M. Pitson. (2016). Recent advances in the development of sphingosine kinase inhibitors. Cellular Signalling. 28(9). 1349–1363. 79 indexed citations
13.
Helbig, Karla J., David P. Dimasi, Michael R. Beard, et al.. (2015). Dengue Virus Infection of Primary Endothelial Cells Induces Innate Immune Responses, Changes in Endothelial Cells Function and Is Restricted by Interferon-Stimulated Responses. Journal of Interferon & Cytokine Research. 35(8). 654–665. 31 indexed citations
14.
Wallington‐Beddoe, Craig T., et al.. (2014). Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing MYC Expression. Cancer Research. 74(10). 2803–2815. 62 indexed citations
15.
Zebol, Julia R., Paul A.B. Moretti, Peng Li, et al.. (2008). The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1. The International Journal of Biochemistry & Cell Biology. 41(4). 822–827. 15 indexed citations
16.
Moretti, Paul A.B., et al.. (2006). The Calmodulin-binding Site of Sphingosine Kinase and Its Role in Agonist-dependent Translocation of Sphingosine Kinase 1 to the Plasma Membrane. Journal of Biological Chemistry. 281(17). 11693–11701. 64 indexed citations
17.
Thompson, Christopher R. L., Shankar S. Iyer, Rebecca L. VanOosten, et al.. (2005). Sphingosine Kinase 1 (SK1) Is Recruited to Nascent Phagosomes in Human Macrophages: Inhibition of SK1 Translocation by Mycobacterium tuberculosis. The Journal of Immunology. 174(6). 3551–3561. 86 indexed citations
18.
Pitson, Stuart M., Paul A.B. Moretti, Julia R. Zebol, et al.. (2002). The Nucleotide-binding Site of Human Sphingosine Kinase 1. Journal of Biological Chemistry. 277(51). 49545–49553. 90 indexed citations
19.
Xia, Pu, Jennifer R. Gamble, Lijun Wang, et al.. (2000). An oncogenic role of sphingosine kinase. Current Biology. 10(23). 1527–1530. 347 indexed citations
20.
Pitson, Stuart M., Alphons G. J. Voragen, Jean‐Paul Vincken, & G. Beldman. (1997). Action patterns and mapping of the substrate-binding regions of endo-(1 → 5)-α-l-arabinanases from Aspergillus niger and Aspergillus aculeatus. Carbohydrate Research. 303(2). 207–218. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher K. Patil Breakdown of academic impact, for papers by Besim Öğretmen Breakdown of academic impact, for papers by Neil J. Bulleid Breakdown of academic impact, for papers by Gordon C. Shore Breakdown of academic impact, for papers by Robert Ballotti Breakdown of academic impact, for papers by Hideki Nishitoh Breakdown of academic impact, for papers by Marı́a S. Soengas Breakdown of academic impact, for papers by Estela E. Medrano Breakdown of academic impact, for papers by Nicholas Joza Breakdown of academic impact, for papers by Éva Szegezdi
Rankless by CCL
2026